Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma.
Shamsian
Bibi Shahin
BS
Goudarzipour
Kourosh
K
Alavi
Samin
S
Jadali
Farzaneh
F
Gharib
Atoosa
A
Aghakhani
Roxana
R
Arzanian
Mohammad Taghi
MT
Rezaei
Nima
N
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000627:therapeutic use; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D014750:Vincristine; D014747:Vinblastine; D016572:Cyclosporine; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate